Literature DB >> 31465846

Genomic perspective of triazole resistance in clinical and environmental Aspergillus fumigatus isolates without cyp51A mutations.

Cheshta Sharma1, Shijulal Nelson-Sathi2, Ashutosh Singh1, M Radhakrishna Pillai3, Anuradha Chowdhary4.   

Abstract

Aspergillus fumigatus is the most common etiologic agent of primarily all clinical manifestations of aspergillosis. A steady increase in the number of azole resistant A. fumigatus (ARAF) isolates from environment and clinical samples leading to therapeutic failures in clinical settings have alarmed the mycologists and clinicians worldwide. Although mutations in azole target cyp51A gene have been implicated in conferring azole resistance in A. fumigatus, recent studies have demonstrated occurrence of azole resistant strains without cyp51A mutations. In this study, next generation sequencing techniques and the expression profiling of transporter genes with single nucleotide polymorphisms (SNPs) in clinical and environmental ARAF isolates with (G54E) and without known cyp51A mutations was undertaken to understand the genetic background and role of transporters in azole resistance. The raw reads of four ARAF strains when mapped to Af293 reference genome (>100X depth) covered at least 93.1% of the reference genome. Among all four strains, a total of 212,711 SNPs was identified with 37,829 were common in at least two isolates. The expression analysis suggested the overexpression of MFS transporter, namely, mfsC in all ARAF isolates. None of the resistant strain showed significant upregulation of cyp51A and cyp51B gene. On the other hand, abcD was upregulated (5-fold) in the isolates with cyp 51A mutation (G54E). The whole genome sequence analysis showed the presence of two previously described amino acid substitutions S269F and F390Y in HMG1 gene in a clinical panazole resistant strain without cyp51A mutations. These mutations have been previously associated with azole resistance in A. fumigatus strains without cyp51A mutations. Further, several punctual mutations and a large-segment deletion among different strains were observed suggesting the involvement of resistance mechanisms other than cyp51A.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Azole resistant Aspergillus fumigatus; ERG6; HMG1; Non-cyp51A mechanism; Whole genome sequencing; abcD; mfsC

Mesh:

Substances:

Year:  2019        PMID: 31465846     DOI: 10.1016/j.fgb.2019.103265

Source DB:  PubMed          Journal:  Fungal Genet Biol        ISSN: 1087-1845            Impact factor:   3.495


  16 in total

Review 1.  Aspergillus fumigatus and aspergillosis: From basics to clinics.

Authors:  A Arastehfar; A Carvalho; J Houbraken; L Lombardi; R Garcia-Rubio; J D Jenks; O Rivero-Menendez; R Aljohani; I D Jacobsen; J Berman; N Osherov; M T Hedayati; M Ilkit; D James-Armstrong; T Gabaldón; J Meletiadis; M Kostrzewa; W Pan; C Lass-Flörl; D S Perlin; M Hoenigl
Journal:  Stud Mycol       Date:  2021-05-10       Impact factor: 16.097

2.  Mitochondrial dysfunctions trigger the calcium signaling-dependent fungal multidrug resistance.

Authors:  Yeqi Li; Yuanwei Zhang; Chi Zhang; Hongchen Wang; Xiaolei Wei; Peiying Chen; Ling Lu
Journal:  Proc Natl Acad Sci U S A       Date:  2019-12-06       Impact factor: 11.205

3.  Deletion of cox7c Results in Pan-Azole Resistance in Aspergillus fumigatus.

Authors:  Mingcong Chen; Guowei Zhong; Sha Wang; Peiying Chen; Lei Li
Journal:  Antimicrob Agents Chemother       Date:  2022-06-01       Impact factor: 5.938

4.  Emergence of W272C Substitution in Hmg1 in a Triazole-Resistant Isolate of Aspergillus fumigatus from a Chinese Patient with Chronic Cavitary Pulmonary Aspergillosis.

Authors:  Tianyu Liang; Xinyu Yang; Ruoyu Li; Ence Yang; Qiqi Wang; Nir Osherov; Wei Chen; Zhe Wan; Wei Liu
Journal:  Antimicrob Agents Chemother       Date:  2021-06-17       Impact factor: 5.191

5.  Guide to the Larval Zebrafish-Aspergillus Infection Model.

Authors:  Taylor J Schoen; Anna Huttenlocher; Nancy P Keller
Journal:  Curr Protoc       Date:  2021-12

Review 6.  Detecting Azole-Antifungal Resistance in Aspergillus fumigatus by Pyrosequencing.

Authors:  Mireille H van der Torre; Lilyann Novak-Frazer; Riina Rautemaa-Richardson
Journal:  J Fungi (Basel)       Date:  2020-01-10

Review 7.  Drug-Resistant Fungi: An Emerging Challenge Threatening Our Limited Antifungal Armamentarium.

Authors:  Amir Arastehfar; Toni Gabaldón; Rocio Garcia-Rubio; Jeffrey D Jenks; Martin Hoenigl; Helmut J F Salzer; Macit Ilkit; Cornelia Lass-Flörl; David S Perlin
Journal:  Antibiotics (Basel)       Date:  2020-12-08

8.  Triazole-Resistant Aspergillus fumigatus in an Israeli Patient with Chronic Cavitary Pulmonary Aspergillosis Due to a Novel E306K Substitution in Hmg1.

Authors:  Mariana Handelman; Alma Morogovsky; Wei Liu; Ronen Ben-Ami; Nir Osherov
Journal:  Antimicrob Agents Chemother       Date:  2021-07-19       Impact factor: 5.191

9.  In Vitro Activity of APX2041, a New Gwt1 Inhibitor, and In Vivo Efficacy of the Prodrug APX2104 against Aspergillus fumigatus.

Authors:  Shareef K Shaheen; Praveen R Juvvadi; John Allen; E Keats Shwab; D Christopher Cole; Yohannes G Asfaw; Mili Kapoor; Karen Joy Shaw; William J Steinbach
Journal:  Antimicrob Agents Chemother       Date:  2021-07-26       Impact factor: 5.191

10.  Caenorhabditis elegans-Based Aspergillus fumigatus Infection Model for Evaluating Pathogenicity and Drug Efficacy.

Authors:  Chukwuemeka Samson Ahamefule; Qijian Qin; Arome Solomon Odiba; Siqiao Li; Anene N Moneke; James C Ogbonna; Cheng Jin; Bin Wang; Wenxia Fang
Journal:  Front Cell Infect Microbiol       Date:  2020-06-26       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.